NKTR
Nektar Therapeutics · Healthcare
President and CEO Howard W Robin sold $1.2M of Nektar Therapeutics
Sold$1,215,056
$60.75Price
20,000Shares
−27%Stake
What NKTR did after the filing
- The stock from Mon, Jun 22 open, $62.30
- +16.8%
- S&P 500, same days
- +3.2%
Measured over 30 trading days, to the Aug 4 close.
Traded Tue, Jun 16. Filed Thu, Jun 18, 7:08 PM ET, after the close. Returns use the Jun 22 open and the Aug 4 close. Not investment advice.